Weight Regain After Stopping a GLP-1
When the STEP 1 trial ended, everyone stopped the drug and the lifestyle program at once. A year later they had regained two-thirds of everything they'd lost. This projects that curve onto your numbers — it's the single most useful thing to know before you start, not after.
What comes back
Weight 12 months after stopping
—
You lost
—
Regained
—
Still down
—
Share of loss regained
—
Half of it is back by
—
If you'd stayed on
—
Where the curve comes from
STEP 1 trial extension — Wilding et al., Diabetes, Obesity and Metabolism 2022. Participants had lost a mean of 17.3% of body weight at week 68. Treatment and the lifestyle program stopped there. One year later, 11.6 of those percentage points had come back, leaving 5.6% net. That's 67% of the loss regained in twelve months. SURMOUNT-4 found the same pattern for tirzepatide, and SELECT's extension confirmed it holds over longer horizons.
The regain curve is modelled as the mirror image of the loss curve — an exponential approach to full regain, with the time constant back-solved so that month 12 lands exactly on the published 67%:
regained(m) = lost × (1 − e−m/10.9), with m in months
It asymptotes toward your original weight and never overshoots it, which is the conservative reading of the data. Beyond twelve months you're past the published follow-up and the page flags it.
Worked example
You start at 240 lb and stop at 190 — a 50 lb loss. Six months off, the model puts you at 211 lb: 21 lb back, 29 still gone. At twelve months you're at 223 lb, having regained 33 lb and kept 17. Half the loss is gone by month 7.6, which is the number most people find genuinely surprising — it isn't a slow drift, it's most of the way back inside a year.
Why it happens — and what it isn't
It isn't a failure of willpower and it isn't a rebound effect peculiar to these drugs. The appetite signalling these medications supply is doing continuous work; when it stops, hunger returns to where it was, and resting metabolic rate is now lower because you're a smaller person. The same regain curve shows up after any successful weight loss intervention that ends. What's different here is that the intervention is a prescription you can simply stop filling — and in the US, insurance changes, job changes, and supply gaps mean plenty of people stop without choosing to.
The practical implication is a planning one: if a GLP-1 is a 12-to-18-month project in your head, the arithmetic says it's closer to indefinite. That's not an argument against taking one — it's an argument for pricing it honestly. The cost calculator has the maintenance side.
What this can't know
In STEP 1 the lifestyle program stopped along with the drug, which is the worst case. People who taper rather than stop cold, who keep the resistance training, or who move to a lower maintenance dose do better than this curve — though how much better isn't well quantified yet. Treat this as the default trajectory if nothing changes, not as a verdict.
FAQ
Does the regained weight come back as fat?
Disproportionately, yes. Weight lost on a GLP-1 is roughly 25–40% lean mass; weight regained after stopping is mostly fat. That means a full on-then-off cycle can land you back at your starting weight with a worse body composition than you began with. Building the resistance-training habit before you stop is the mitigation. See the protein and muscle calculator.
Can I taper instead of stopping?
Many prescribers do step the dose down rather than stop abruptly, and it's a reasonable approach — but there's no trial that establishes tapering prevents regain, only clinical experience suggesting it softens the transition. Don't change your own dose to test it; that's a prescriber conversation.
What if I stop because of side effects, not by choice?
The curve is the same — it depends on the drug being absent, not on why. If cost or supply is the reason, it's worth asking about a different agent in the class or a lower maintenance dose before stopping entirely, since holding any effective dose beats the regain trajectory.
Does the drug still work if I restart?
Yes. There's no evidence of tolerance in the sense of the drug losing potency, and re-treatment produces loss again. The cost is the round trip — a year of regain and then another year of losing the same weight, paid for twice.
Is this medical advice?
No. It's a published trial curve applied to your numbers. Whether, when, and how to stop a prescription is a decision for you and your prescriber, and nothing here should substitute for that conversation.
Estimate — not medical advice
This is an estimate, not medical advice, and not a diagnosis. It doesn't know your history, your medications, or your other results, and it should never be used to start, stop, or change treatment. If a number here concerns you, take it to a doctor or pharmacist rather than acting on it.